Events Archives - Page 77 of 128

3 minute read

Merus’ Petosemtamab Interim Data Demonstrates Clinically Meaningful Activity In Previously Treated Head And Neck Squamous Cell Carcinoma

April 17, 10:17 AM

- 37% overall response rate (ORR) observed in 43 evaluable patients - 6 months median duration of response as of Feb. 1, 2023 data cutoff date - End-of-phase meeting with U.S. Food & Drug Administration

MRUS

4 minute read

Allogene Therapeutics Presents Interim Phase 1 Data On ALLO-316 In Renal Cell Carcinoma At The American Association Of Cancer Research Annual Meeting

By Happy Mohamed

April 17, 10:17 AM

Data Provide Proof-of-Concept for an Allogeneic Anti-CD70 CAR T Candidate in Patients with Renal Cell Carcinoma (RCC) Who Received Prior Immune Checkpoint Inhibitor and VEGF-Targeting Therapy Single Infusion

ALLO

3 minute read

Elevation Oncology Presents EO-3021 Preclinical Proof-Of-Concept Data And Highlights A Clinical Case Study In Claudin 18.2-Expressing Cancers At AACR 2023

By Happy Mohamed

April 17, 10:16 AM

EO-3021 demonstrated anti-tumor activity in preclinical models expressing varying levels of Claudin 18.2 EO-3021 induced a confirmed partial response in a patient with metastatic gastric cancer Company is on track to

ELEV

5 minute read

Zentalis Announces Preclinical Data Supporting Cyclin E1 As A Predictive Marker For Azenosertib Treatment At AACR Annual Meeting 2023

By Happy Mohamed

April 17, 9:09 AM

Data suggest Cyclin E1 plays a critical role in high proportion of multiple tumor types including platinum-resistant ovarian cancer Company anticipates sharing clinical data from ovarian chemotherapy combination

ZNTL

3 minute read

Precigen Presents Preclinical Data For The Next Generation Mesothelin UltraCAR-T With Intrinsic PD-1 Blockade At The AACR Annual Meeting 2023

By Happy Mohamed

April 17, 9:03 AM

– First preclinical data presented for the next generation of the UltraCAR-T platform utilizing a mesothelin (MSLN) chimeric antigen receptor (CAR) – – MSLN is overexpressed on multiple solid

PGEN

3 minute read

IN8bio Announces Preclinical Data For Gamma-Delta CAR Platform And Launches New CD33 Program At AACR Annual Meeting 2023

By Happy Mohamed

April 17, 9:02 AM

INB-300, a gamma-delta T cell chimeric antigen receptor (CAR) platform, demonstrated the ability to target cancer cells while sparing healthy tissue when both express the CAR-targeted antigen. CAR platform

INAB

2 minute read

Reported Ealier, Cellectis Presents Preclinical Data On TALEN-Edited MUC1 CAR T-Cells To Enhance Efficacy In Targeting Triple Negative Breast Cancer At The American Association For Cancer Research Annual Meeting

By Happy Mohamed

April 17, 8:46 AM

Cellectis (the "Company") (NASDAQ:CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today released preclinical data on

CLLS

3 minute read

EXCLUSIVE: Ketamine Therapy Leaders Share Bold Vision For Future At Benzinga’s Psychedelics Capital Conference

By Lara Goldstein

April 14, 11:36 AM

At the second edition of Benzinga’s Psychedelics Capital Conference, held in sunny Miami, leaders from four major ketamine therapy companies shared their optimistic insights and guidance about the industry.

RVLWF

4 minute read

Merus Announces Publication Of An Abstract On Petosemtamab Monotherapy In Previously Treated Head And Neck Squamous Cell Carcinoma For Plenary Session Oral Presentation At The AACR Annual Meeting 2023 And Provides A Program And Regulatory Update

By Happy Mohamed

April 14, 11:12 AM

- Robust 36% overall response rate (ORR) in 42 evaluable patients - 6 months median duration of response with 17 patients still on treatment as of Nov. 28, 2022 data cutoff - End-of-Phase meeting with

MRUS

2 minute read

Curaleaf Expanding Its Footprint In Florida With 59th Dispensary And Plans For More To Come

By Maureen Meehan

April 14, 9:36 AM

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) announced Friday that it is opening Curaleaf Boca Raton Glades, the company's 59th dispensary in Florida and 151st nationwide. Located at 7875 Glades Rd, Boca Raton, FL 33434, the new shop is t

CSE:CURA